The Life Raft Group is committed to enhancing the survival and quality of life for people living with Gastrointestinal Stromal Tumor (GIST), and other rare diseases, through patient-powered research, education and empowerment, and global advocacy efforts.
Other Programs Supported by The Life Raft Group:
PATIENT
Leverage patient perspective to drive innovative solutions in cancer research.
POWERED
Educate and empower patients to take a larger role in their care.
SCIENCE
Accelerate research outcomes through collaborative efforts.
FOR LIFE
Increase access to effective treatments worldwide.
Real World Evidence In Action
Traditional models for cancer research have resulted in many breakthrough treatments for patients, but it is not enough. The LRG’s approach to GIST research through real world evidence, relies on timely, accurate data from the patient’s perspective, with patient survival as the primary objective.
RECENT LRG DATA
Did you know that GIST is actually a family of cancers? Learn more about the science of GIST.
Update your Patient Registry Info.
Join The Life Raft Group.
Current GIST Clinical Trials.
Search the GIST Specialist Database.
Dr. Monica Anderson
Diagnosed in 2012 with Adult GIST.
Bella Rocco
Diagnosed in 2009 with Pediatric
(SDH-deficient) GIST.
HELP US SAVE LIVES
The Life Raft Group is a community and it is up to all of us to make a difference. There are many ways to help. We always need patient tissue and data in our GIST patient registry. Volunteering your time or making a monetary donation also helps us drive research forward and save lives.
News
The Future of Research for Rare Cancers
Two recent articles highlight the need to focus attention on cancers that have previously been less widely acknowledged by both funding [...]
Affect Change From The Top: A GIST Advocacy Primer
In preparation for July 13th's GIST Awareness Day we have invited top advocates to share their best strategies on how to campaign for change and raise awareness about GIST.
Epigenomics – A new frontier in research
In a recent article from Biomed Central, the importance of epigenomics and the Human Genome Project and more recent cancer- focused initiatives [...]
Results from collaborative trial announced at ASCO
At the recent American Society of American Oncology Meeting (ASCO), Dr. George Demetri, Director of the Center for Sarcoma and Bone Oncology, [...]
How Do Immunotherapy Drugs Work?
A recent article from Cancer Research UK discusses immunotherapy, and the attention its role in the future of cancer treatment may [...]
Long-term benefits from targeted therapy for GIST
George Demetri, MD, Senior Vice President for Experimental Therapeutics at Dana-Farber Cancer Institute, discusses the lasting benefit of targeted therapy that included [...]
Innovative Immunotherapy Treatments Garner Attention
New research on innovative immunotherapy treatments was presented at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO). Immunotherapy [...]
White Out Cancer day announced by the Cancer Research Institute
Today is White Out Cancer Day. In order to honor Cancer Immunotherapy Month, The Cancer Research Institute is encouraging everyone to wear [...]
Keep up with the latest news, events, and opportunities to help.
To contact The Life Raft Group, please call 973-837-9092
PARTNERS & AFFILIATIONS
